Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 711 shares at $30.03 ($21K) on 2021-09-17, disclosed to the SEC on 2021-09-21.
Scheduled sale ($21k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |